Send us message to learn more about InnoHK
CONTACT US
Chinese Medicine
Centre for Chinese Herbal Medicine Drug Development
Traditional Wisdom Innovative Drugs
Hong Kong has assumed a bridging role and as such is making an important contribution to the introduction of traditional Chinese medicine in the international arena. We are confident that the Centre will play a key role in Hong Kong’s development as a research hub that will advance the modernization of Chinese medicine to achieve major breakthroughs in disease treatment. Ultimately, the Centre’s work will improve outcomes for patients in Hong Kong, the Greater Bay Area and worldwide.
Professor BIAN Zhaoxiang
Director, Centre for Chinese Herbal Medicine Drug Development Limited
Traditional Wisdom Innovative Drugs
For thousands of years, Chinese medicine was used in the prevention and treatment of diseases as well as for health maintenance through strengthening and enhancing normal body functions. In recent years, Hong Kong has focused on the translation of Chinese medicinal wisdom into pharmaceutical products using cutting-edge technology. A number of new Chinese Herbal Medicine (CHM) based drugs have been successfully developed in Hong Kong and used for different treatments of diseases. One notable success was a drug co-developed by the Hong Kong Baptist University and the Chinese University of Hong Kong for treating irritable bowel syndrome.
Our vigorous team consists of experts in Chinese medicine, microbiology, pharmacognosy, pharmacology, clinical trials and bioinformatics. We work together to create and accumulate outputs that are both innovative and impactful for the treatment of patients.
The Centre is established to perform Chinese herbal medicine research in Hong Kong through collaboration with local and international partners.
The Centre develops treatments and cures for gastrointestinal diseases such as ulcerative colitis and chronic constipation.
To accelerate the development of CHM-based drugs, the Centre for Chinese Herbal Medicine Drug Development Limited (the Centre) has been established as a strategic platform for promoting collaborations among local and international researchers, institutions and the industry. The Centre aims to enhancing the quality of pre-clinical and clinical CHM research and transforming the results into pharmaceutical products for international markets. In particular, it develops treatments and cures for diseases such as ulcerative colitis and chronic constipation.
The Centre will create a platform for the development of CHM-based drugs, including the functional units of pre-clinical and clinical studies such as pharmacognosy, pharmacology, toxicology, pharmacokinetics/ pharmacodynamics, omics and bioinformatics. It also supports the incubation of new CHM-based pharmaceutical start-ups that will target global markets, and nurtures talent for CHM research in Hong Kong. The Centre is also prepared to facilitate the development of the first-ever Chinese Medicine Hospital in Hong Kong which will be in operation by 2024.
Project team members
-
Professor BIAN ZhaoxiangDirector
In this project
You may also like
Centre for Regenerative Medicine and Health, Hong Kong Institute of Science & Innovation, Chinese Academy of Sciences
